Error during command authentication.

Error - unable to initiate communication with LISTSERV (errno=10061, phase=CONNECT, target=127.0.0.1:2306). The server is probably not started.

Calling all foreign-born or international students (Asia, Africa, Canada, Latin America, Europe) to participate in a voluntary medical study with compensation.

Dr. Ford Von Reyn, professor at the Geisel School of Medicine and principal investigator of the study is working on a study at the Dartmouth Hitchcock Medical Center to test a new booster vaccine against TB known as DAR-901. Since the vaccine is a booster it is intended for foreign-born persons who received the standard TB vaccine (BCG) at birth. 

A news release on the vaccine can be found on the first link and detailed information on the study in the second link:

Geisel School of Medicine - Dartmouth and Aeras Join Forces to Conduct Study of New Tuberculosis Vaccine
 
 
 
Geisel School of Medicine - Dartmouth and Aeras Join For...
Geisel School of Medicine - Dartmouth and Aeras Join Forces to Conduct Study of New Tuberculosis Vaccine
 
Preview by Yahoo
 

TB vaccine study at Dartmouth
 
 
TB vaccine study at Dartmouth
Geisel School of Medicine at Dartmouth
 
Preview by Yahoo
 

The research team is looking for foreign-born volunteers who are willing to  to participate in a 10-month long study and receive 3 doses of this investigational vaccine, have blood tests and 10 visits over 10 months.  Volunteers will be compensated for their time with up to 600 dollars, and if you qualify for this study and are interested in participating please contact Shay Vellanki at [log in to unmask] and she will put you in contact with Dr. Von Reyn.

If you have any questions about the study please do not hesitate to contact Dr. Von Reyn at [log in to unmask] or Dr. Lisa Adams at [log in to unmask] about their research.

We will be tabling at Collis later this week during lunch hours on Thursday and Friday to provide more information about the study and allow for people to sign up and provide us with contact information, so stay tuned for more updates!​